LINEZOLIDFORMULIERUNGEN

European patent · EP3709970 · In force

Register entry

Publication number
EP3709970
Application number
EP18808077
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 16, 2018
Published
Sep 23, 2020
Granted
May 14, 2025
Protection ends at the latest
Nov 15, 2038
Next annual fee due
Nov 30, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 31/5377 (2006.01)
A61K 47/10 (2017.01)
A61K 49/04 (2006.01)
A61K 9/06 (2006.01)
Priority
US 201762587101 P 16.11.2017
PCT application
PCT/GB2018/053319 16.11.2018
PCT publication
WO2019/097242 23.05.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 25, 2026

    Change

    Published in Swissreg on 25.03.2026

  2. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  3. May 14, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 14.05.2025

Parties

Holder

Persica Pharmaceuticals Ltd.

7 Denne Hill Business Centre Womenswold, Canterbury, Kent CT4 6HD, GB

Inventor

CZAPLEWSKI, Lloyd

Canterbury Kent CT4 6HD, GB

GUEST, Sarah

Canterbury Kent CT4 6HD, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.